R. Mel

发表

A dose-dense schedule of docetaxel followed by doxorubicin and cyclophosphamide as neoadjuvant treatment for breast cancer: results from a phase II study

M. Ramos, L. Calvo, A. González, 2011, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

Phase II study of a fixed dose-rate infusion of gemcitabine associated with uracil/tegafur in advanced carcinoma of the pancreas.

E. Espinosa, J. Feliu, J. Castro, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase II study of dose-dense doxorubicin and docetaxel as neoadjuvant chemotherapy with G-CSF support in patients with large or locally advanced breast cancer

M. Ramos, L. Calvo, J. García-Mata, 2008 .